Shopping Cart
- Remove All
Your shopping cart is currently empty
CC-401 is a specific inhibitor of JNK (Ki: 25-50nM).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $383 | 35 days | |
| 5 mg | $1,680 | 35 days | |
| 10 mg | $2,870 | 35 days |
| Description | CC-401 is a specific inhibitor of JNK (Ki: 25-50nM). |
| Targets&IC50 | JNK:25-50 nM (Ki) |
| In vitro | CC-401 is a second-generation ATP-competitive inhibitor of all three forms of JNK. It is selective against JNK over other kinases such as p38, ERK, IKK2, and ZAP70. CC-401 potently inhibits JNK in cell-based assay with a concentration of 1 to 5μM. The activation of JNK signaling is identified in many immune-mediated kidney disease models. Thus, as the JNK inhibitor, CC-401 is found to be effective in these renal injury models. In the acute anti-GBM disease, CC-401 inhibits JNK activation and causes a 50%-70% reduction of proteinuria. In addition, CC-401 is also used in liver injury models [1][2][3]. |
| Molecular Weight | 388.47 |
| Formula | C22H24N6O |
| Cas No. | 395104-30-0 |
| Relative Density. | 1.275 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: ≥19.4 mg/mL, Sonication is recommended. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.